May 23, 2024
Unleashing the Power of Cell and Gene Therapy
Tarrytown, NY

Date: Thursday, May 23, 2024
Time: 12:00pm – 5:00pm EDT
Location: Regeneron Pharmaceuticals Headquarters
777 Old Saw Mill River Road Tarrytown, NY 10591

· LifeSciencesNY Member: $53.64
· Future Member: $79.57

Register Here

Join us on Thursday, May 23 at the headquarters of Regeneron Pharmaceuticals in Tarrytown as we bring together leading researchers, product developers, and cutting-edge startups for a statewide symposium focused on challenges, collaboration and opportunities in the field.

The program will include:
Two interactive panel discussions featuring:

  • Leading researchers from New York State universities on the state of Cell and Gene Therapy research, best practices, and addressing identified challenges;
  • Representatives from New York-based life sciences companies on the use and application of Cell and Gene Therapy in drugs and other healthcare products.
  • A spotlight conversation with New York healthcare startups focused on Cell and Gene Therapy.
  • Active networking and opportunities for collaboration and partnership.

Lunch is included and the program will conclude with a networking reception from 4-5 pm.

Advancements in Cell & Gene Therapy (CGT), along with a significant state investment, are paving the way for New York to become the nation’s leader in transformative, life-enhancing and life-saving medical treatments. Join us on May 23 as we bring together researchers, industry representatives, and innovative startups to identify opportunities and tackle challenges in CGT and its related fields.

Keynote speaker, Meghan Drummond will explore how CGT has the potential to alleviate the impacts of genetic disease and will share how Regeneron Pharmaceuticals is employing this technology to overcome profound hearing loss in children.

Researchers Ailong Ke of Cornell UniversityYanling Liao of Westchester Medical CenterZhiqiang Lin of the Masonic Medical Research Institute, and Susan Sharfstein of the RNA Institute at the University at Albany will discuss their research and the potential CGT holds to transform our approach to medical care.

Industry representatives Christopher Choi of Roswell Park Comprehensive Cancer CenterGeoff Horowitz of RegeneronTammy Joska of Thrive Bioscience and Meg Wood of New York Blood Center will address current applications of CGT in the commercial realm and explore future product uses of this technology.

Sit in on our conversation with founders Tal Gilat of NeuroGenesisGeorge Goldberger of Cell One PartnersChris Hempel of Expressive Neuroscience and Karen Torrejon of Humonix Bio to learn how these startups are employing CGT to revolutionize the diagnosis and treatment of genetic disease.

Lunch is included and the program will conclude with a networking reception from 4-5pm. Stay to meet and connect with colleagues and potential partners in the CGT space.